Epithelioid haemangioendothelioma
Prepared with OnCo (onco.cc/prep/epithelioid-haemangioendothelioma/). Orientation, not medical advice; your team knows your case.
My details
What I know, what is unclear, changes to discuss
Saved in this browserMy questions
13 on the sheet- 1.What is my exact diagnosis, stage, and grade, and which tests established them?
- 2.Which biomarkers have been tested on my tumour (for example WWTR1-CAMTA1 fusion, YAP1-TFE3 fusion, Pleural effusion, serosal involvement and pain, Mitotic count and size), and what were the results?
- 3.Which subtype is my cancer, and does that change the recommended treatment?
- 4.Is germline (inherited) genetic testing recommended for me or my family?
- 5.For my situation (asymptomatic, stable, multifocal), which of the standard options do you recommend and why?
- 6.For my situation (localised), which of the standard options do you recommend and why?
- 7.For my situation (progressive or symptomatic), which of the standard options do you recommend and why?
- 8.Am I a candidate for Everolimus, Sirolimus protein-bound particles, Pazopanib or related drugs, and what side effects should I expect?
- 9.Are there clinical trials I could join, for example of mTOR, Pazopanib?
- 10.Would a second opinion at a high-volume centre change anything, and can you help arrange it?
- 11.What supportive care (symptom control, nutrition, exercise, mental health, financial help) is available from the start?
- 12.I read that “No approved drug and no randomised trial”. How does that affect my plan?
- 13.I read that “Predicting which tumours will progress is unreliable”. How does that affect my plan?
Tests and results to bring
Biomarker results to ask for: WWTR1-CAMTA1 fusion (CAMTA1 immunohistochemistry), YAP1-TFE3 fusion (TFE3 immunohistochemistry), Pleural effusion, serosal involvement and pain (aggressive phenotype), Mitotic count and size (risk stratification).
Scans and tests linked to this cancer: Active surveillance, CT (computed tomography), MRI.
Bring copies of scan reports, pathology and blood results, and a list of every medicine and supplement.
The treatments I may be offered
- Localised: Complete resection; liver transplantation for unresectable liver-limited disease; radiotherapy for bone lesions. (Limb-salvage surgery and endoprosthetic reconstruction, Liver transplantation for cancer (Milan criteria and beyond), IMRT / IGRT (modern external beam))
- Asymptomatic, stable, multifocal: Active surveillance with imaging every three to six months; treat only on progression or symptoms. (Active surveillance, CT (computed tomography), MRI)
- Progressive or symptomatic: Sirolimus or another mTOR inhibitor first; pazopanib or other anti-angiogenic kinase inhibitors; anthracycline chemotherapy for rapidly progressive disease. (mTOR, Everolimus, Sirolimus protein-bound particles, Pazopanib, Doxorubicin, Paclitaxel / nab-paclitaxel)
From the standard of care recorded for this cancer; which apply depends on your stage and biomarkers. Ask which the team recommends and why.